China Universal Asset Management Company’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
BC
CMF
HWAM
ETC
PFSRSONJ
CG
EWM
VCM
China Universal Asset Management Company's NVCR Position: Q2 2026 in Review
China Universal Asset Management Company reduced its NovoCure (NVCR) stake by 8.7% in Q2 2026, selling an estimated $26.6K and leaving 18,433 shares worth $279K. The position accounts for 0.02% of the portfolio, ranked #327.
China Universal Asset Management Company first reported a position in NVCR in Q3 2022 and has held it in 16 quarters since. The position peaked at $684K in Q4 2024. 34 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.
- China Universal Asset Management Company held 18,433 shares of NovoCure worth $279K as of Q2 2026.
- China Universal Asset Management Company sold 1,761 NovoCure shares in Q2 2026, an estimated $26.6K.
- NovoCure made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #327 holding.
- China Universal Asset Management Company first reported a position in NovoCure in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's NovoCure position peaked at $684K in Q4 2024.
- 34 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.